Urogen Pharma (URGN) Presents At Oppenheimer 31st Annual Healthcare Conference - Slideshow

UROGEN PHARMA OPPENHEIMER 31ST ANNUAL HEALTHCARE CONFERENCE MARCH 16, 2021 2 Forward Looking Statements This investor presentation contains forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995, including, without limitation: the potential market opportunity of Jelmyto in LG-UTUC; commercial plans for favorable market access and both patient and physician uptake; expected interest in prescribing Jelmyto; the continued successful launch of Jelmyto; the pot ...